Description

Nomigren Bosnalek (ergotamine tartrate) coated tablets №10

Ingredients

Each coated tablet contains:

• Ergotamine tartrate
• Excipients

Dosage

Adults: The usual dose is 1 to 2 tablets at the onset of a migraine headache. Do not exceed 6 tablets in 24 hours.

Indications

Nomigren Bosnalek coated tablets are indicated for the acute treatment of migraine attacks with or without aura.

Contraindications

Do not use Nomigren Bosnalek coated tablets if:

• You have a history of peripheral vascular disease
• You are pregnant or breastfeeding
• You have severe hepatic or renal impairment

Directions

Swallow the tablets whole with water. Do not crush or chew them. If the headache persists or worsens after taking the medication, seek medical advice.

Scientific Evidence

Ergotamine tartrate, the active ingredient in Nomigren Bosnalek tablets, has been extensively studied for its efficacy in treating migraines. Research published in the Journal of Headache and Pain has shown that ergotamine derivatives are effective in relieving moderate to severe migraine attacks.

Additional Information

It is important to note that Nomigren Bosnalek tablets should not be used for prophylaxis and are intended for acute migraine treatment only. Consult a healthcare professional before starting any new medication, especially if you have any underlying health conditions or are taking other medications.

The pharmacological action of ergotamine involves vasoconstriction and inhibition of neurogenic inflammation, which are believed to contribute to its anti-migraine effects. Clinical trials have demonstrated the efficacy of ergotamine in reducing the intensity and duration of migraine attacks, making it a valuable option for patients suffering from this debilitating condition.